FDA Grants Datopotamab Deruxtecan Approval for ...

By Rene Pretorius

January 24, 2025

The FDA approved datopotamab deruxtecan (Datrow...
Promising Dual Immunotherapy for Anaplastic Thyroid Cancer
Thyroid Eye Disease Therapy: Insights from Viridian Therapeutics’ THRIV...
Promising Results for Imlunestrant in Advanced ER+ HER2- Breast Cancer
Heplisav-B: A Superior Hepatitis B Vaccine for Individuals with HIV
Zepbound Outperforms Wegovy in Weight Loss Trial
Dark Chocolate: A Sweet Ally Against Type 2 Diabetes and More
Improving Cervical Cancer Screening: HPV Self-Collection Tests
Overview of NICE’s Elranatamab Managed Access Agreement
HARMONi-2 Trial Results Transforming NSCLC
KEYTRUDA Head Neck Cancer Phase 3 Trial
UNAIDS Urges Greater Access for Gilead’s Lenacapavir
FDA Approves Inavolisib Breast Cancer Treatment